Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.

@article{Huurman2006ChoiceOA,
  title={Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.},
  author={V A L Huurman and Jayant S Kalpoe and Pieter van de Linde and Norbert Vaessen and Jan Ringers and Aloys C. M. Kroes and Bart O. Roep and J W de Fijter},
  journal={Diabetes care},
  year={2006},
  volume={29 4},
  pages={
          842-7
        }
}
  • V A L Huurman, Jayant S Kalpoe, +5 authors J W de Fijter
  • Published in Diabetes care 2006
  • Medicine
  • OBJECTIVE Simultaneous pancreas-kidney (SPK) transplantation in type 1 diabetic patients requires immunotherapy against allo- and autoreactive T-cells. Cytomegalovirus (CMV) infection is a major cause for morbidity after transplantation and is possibly related to recurrent autoimmunity. In this study, we assessed the pattern of CMV viremia in SPK transplant recipients receiving either antithymocyte globulin (ATG) or anti-CD25 (daclizumab) immunosuppressive induction therapy. RESEARCH DESIGN… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 18 CITATIONS

    Encapsulated islets transplantation: Past, present and future.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES

    The use of antibodies against the IL-2 receptor in transplantation.

    VIEW 9 EXCERPTS
    HIGHLY INFLUENTIAL

    Percentage of CMV-specific cells in the CD3

    • DE Sutherland, RW Gruessner, +3 authors R Kandaswamy
    • VOLUME 29,
    • 2006

    : three - year results

    • S Hariharan, CP Johnson, +3 authors D Stablein
    • 2004

    Emerging trends in infections among renal transplant recipients.

    VIEW 1 EXCERPT